Tango Therapeutics annual shares outstanding
2020
2021
2022
2023
2024
2025
Tango Therapeutics Shares Outstanding History (TNGX)
Tango Therapeutics reported 135.9M shares outstanding at the end of fiscal 2025.
View full Tango Therapeutics company overviewTango Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 135.9M | 28.2M | +26.19% |
| 2024 | 2024-12-31 | 107.7M | 5.5M | +5.41% |
| 2023 | 2023-12-31 | 102.2M | 14.0M | +15.90% |
| 2022 | 2022-12-31 | 88.2M | 581,190 | +0.66% |
| 2021 | 2021-12-31 | 87.6M | 47.2M | +116.98% |
| 2020 | 2020-12-31 | 40.4M | — | — |
Tango Therapeutics quarterly shares outstanding
Q3.20
Q4.20
Q1.21
Q2.21
As of Aug 10, 2021
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 168.4M | 57.5M | +51.87% |
| Q1 2026 | 2026-03-31 | 144.2M | 36.1M | +33.35% |
| Q4 2025 | 2025-12-31 | 135.9M | 28.2M | +26.19% |
| Q3 2025 | 2025-09-30 | 111.6M | 4.2M | +3.87% |
| Q2 2025 | 2025-06-30 | 110.9M | 3.8M | +3.58% |
| Q1 2025 | 2025-03-31 | 108.1M | 1.4M | +1.29% |
| Q4 2024 | 2024-12-31 | 107.7M | 5.5M | +5.41% |
| Q3 2024 | 2024-09-30 | 107.4M | 5.6M | +5.47% |
| Q2 2024 | 2024-06-30 | 107.0M | 18.6M | +21.00% |
| Q1 2024 | 2024-03-31 | 106.7M | 18.5M | +21.00% |
| Q4 2023 | 2023-12-31 | 102.2M | 14.0M | +15.90% |
| Q3 2023 | 2023-09-30 | 101.8M | 13.8M | +15.65% |
| Q2 2023 | 2023-06-30 | 88.5M | 464,895 | +0.53% |
| Q1 2023 | 2023-03-31 | 88.2M | 500,465 | +0.57% |
| Q4 2022 | 2022-12-31 | 88.2M | 581,190 | +0.66% |
| Q3 2022 | 2022-09-30 | 88.1M | 523,252 | +0.60% |
| Q2 2022 | 2022-06-30 | 88.0M | 523,710 | +0.60% |
| Q1 2022 | 2022-03-31 | 87.7M | 82.0M | +1427.65% |
| Q4 2021 | 2021-12-31 | 87.6M | 81.9M | +1446.30% |
| Q3 2021 | 2021-09-30 | 87.5M | 81.9M | +1451.92% |
| As of Aug 10, 2021 | 2021-08-10 | 87.5M | 81.8M | +1452.61% |
| Q2 2021 | 2021-06-30 | 5.7M | — | — |
| Q1 2021 | 2021-03-31 | 5.7M | — | — |
| Q4 2020 | 2020-12-31 | 5.6M | — | — |
| Q3 2020 | 2020-09-30 | 5.6M | — | — |
Tango Therapeutics shares outstanding trends
Over the last five reported fiscal years, Tango Therapeutics's shares outstanding moved from 40.4M to 135.9M, a change of 95.6M. The latest reported quarter, Q2 2026, shows 168.4M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tango Therapeutics filings at SEC.gov ↗